InvestorsHub Logo
Followers 145
Posts 27561
Boards Moderated 3
Alias Born 02/07/2004

Re: None

Friday, 09/23/2016 12:12:39 AM

Friday, September 23, 2016 12:12:39 AM

Post# of 3878
RedHill Biopharma Ltd – (NASDAQ:RDHL) has been assigned an average rating of “Buy” from the ten brokerages that are currently covering the stock. Two analysts have rated the stock with a sell recommendation, seven have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average 12 month target price among brokerages that have covered the stock in the last year is $27.60.

http://dailyquint.com/2016-09-22-redhill-biopharma-ltd-nasdaqrdhl-receives-consensus-recommendation-of-buy-from-brokerages/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RDHL News